Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu 610083, China.
Department of Outpatient, The General Hospital of Western Theater Command, Chengdu 610083, China.
Aging (Albany NY). 2023 Oct 18;15(20):11114-11130. doi: 10.18632/aging.205105.
Pulmonary arterial hypertension (PAH) is a poorly prognostic cardiopulmonary disease characterized by abnormal contraction and remodeling of pulmonary artery (PA). Excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) are considered as the major etiology of PA remodeling. As a negative regulator of Wnt/β-catenin pathway, naked cuticle homolog 1 (NKD1) is originally involved in the tumor growth and metastasis via affecting the proliferation and migration of different types of cancer cells. However, the effect of NKD1 on PAH development has not been investigated. In the current study, downregulated NKD1 was identified in hypoxia-challenged PASMCs. NKD1 overexpression by adenovirus carrying vector encoding (Ad-) repressed hypoxia-induced proliferation and migration of PASMCs. Mechanistically, upregulating NKD1 inhibited excessive reactive oxygen species (ROS) generation and β-catenin expression in PASMCs after hypoxia stimulus. Both inducing ROS and recovering β-catenin expression abolished NKD1-mediated suppression of proliferation and migration in PASMCs. , we also observed decreased expression of NKD1 in dissected PAs of monocrotaline (MCT)-induced PAH model. Upregulating NKD1 by Ad- transfection attenuated the increase in right ventricular systolic pressure (RVSP), right ventricular hypertrophy index (RVHI), pulmonary vascular wall thickening, and vascular β-catenin expression after MCT treatment. After recovering β-catenin expression by SKL2001, the vascular protection of external expression of NKD1 was also abolished. Taken together, our data suggest that NKD1 inhibits the proliferation, migration of PASMC, and PAH via inhibition of β-catenin and oxidative stress. Thus, targeting NKD1 may provide novel insights into the prevention and treatment of PAH.
肺动脉高压(PAH)是一种预后不良的心肺疾病,其特征为肺动脉(PA)异常收缩和重塑。肺动脉平滑肌细胞(PASMC)的过度增殖和迁移被认为是 PA 重塑的主要病因。裸皮同源物 1(NKD1)作为 Wnt/β-连环蛋白通路的负调节剂,最初通过影响不同类型癌细胞的增殖和迁移而参与肿瘤生长和转移。然而,NKD1 对 PAH 发展的影响尚未得到研究。在本研究中,在缺氧应激的 PASMC 中鉴定出下调的 NKD1。通过携带载体编码的腺病毒(Ad-)过表达 NKD1 抑制了 PASMC 缺氧诱导的增殖和迁移。在机制上,上调 NKD1 抑制了缺氧刺激后 PASMC 中过量的活性氧(ROS)生成和 β-连环蛋白表达。诱导 ROS 和恢复 β-连环蛋白表达均可消除 NKD1 介导的 PASMC 增殖和迁移抑制。此外,我们还观察到在野百合碱(MCT)诱导的 PAH 模型中分离的 PA 中 NKD1 的表达降低。通过 Ad-转染上调 NKD1 可减轻 MCT 处理后右心室收缩压(RVSP)、右心室肥厚指数(RVHI)、肺血管壁增厚和血管β-连环蛋白表达的增加。在用 SKL2001 恢复 β-连环蛋白表达后,NKD1 外源性表达的血管保护作用也被消除。总之,我们的数据表明,NKD1 通过抑制β-连环蛋白和氧化应激抑制 PASMC 的增殖、迁移和 PAH。因此,靶向 NKD1 可能为 PAH 的预防和治疗提供新的思路。